• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用美国风湿病学会(ACR)和欧洲甲状腺影像报告和数据系统(EU-TIRADS)的诊断标准提高甲状腺结节分类中细胞学检查的效能

Use of Diagnostic Criteria from ACR and EU-TIRADS Systems to Improve the Performance of Cytology in Thyroid Nodule Triage.

作者信息

Seminati Davide, Capitoli Giulia, Leni Davide, Fior Davide, Vacirca Francesco, Di Bella Camillo, Galimberti Stefania, L'Imperio Vincenzo, Pagni Fabio

机构信息

Department of Medicine and Surgery, University of Milano-Bicocca, Pathology, 20900 Monza, Italy.

Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.

出版信息

Cancers (Basel). 2021 Oct 29;13(21):5439. doi: 10.3390/cancers13215439.

DOI:10.3390/cancers13215439
PMID:34771602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8582424/
Abstract

The American College of Radiology (ACR) and the European Thyroid Association (EU) have proposed two scoring systems for thyroid nodule classification. Here, we compared the ability of the two systems in triaging thyroid nodules for fine-needle aspiration (FNA) and tested the putative role of an approach that combines ultrasound features and cytology for the detection of malignant nodules. The scores obtained with the ACR and EU Thyroid Imaging Reporting and Data Systems (TIRADS) from a prospective series of 480 thyroid nodules acquired from 435 subjects were compared to assess their performances in FNA triaging on the final cytological diagnosis. The US features that showed the highest contribution in discriminating benign nodules from malignancies were combined with cytology to improve its diagnostic performance. FNA was recommended on 46.5% and 51.9% of the nodules using the ACR and EU-TIRADS scores, respectively. The ACR system demonstrated a higher specificity as compared to the EU-TIRADS (59.0% vs. 52.4%, = 0.0012) in predicting ≥ TIR3A/III (SIAPEC/Bethesda) nodules. Moreover, specific radiological features (i.e., echogenic foci and margins), combined with the cytological classes improved the specificity (97.5% vs. 91%, < 0.0001) and positive predictive values (77.5% vs. 50.7%, < 0.0001) compared to cytology alone, especially in the setting of indeterminate nodules (TIR3A/III and TIR3B/IV), maintaining an excellent sensitivity and negative predictive value. The ACR-TIRADS system showed a higher specificity compared to the EU-TIRADS in triaging thyroid nodules. The use of specific radiological features improved the diagnostic ability of cytology.

摘要

美国放射学会(ACR)和欧洲甲状腺协会(EU)已经提出了两种甲状腺结节分类评分系统。在此,我们比较了这两种系统对甲状腺结节进行细针穿刺活检(FNA)分类的能力,并测试了一种结合超声特征和细胞学检查来检测恶性结节的方法的假定作用。将从435名受试者中获取的480个甲状腺结节的前瞻性系列中,使用ACR和EU甲状腺影像报告和数据系统(TIRADS)获得的分数进行比较,以评估它们在根据最终细胞学诊断进行FNA分类中的表现。将在区分良性结节与恶性结节方面贡献最大的超声特征与细胞学检查相结合,以提高其诊断性能。分别使用ACR和EU - TIRADS评分时,推荐对46.5%和51.9%的结节进行FNA。在预测≥TIR3A/III(SIAPEC/贝塞斯达)结节方面,ACR系统与EU - TIRADS相比具有更高的特异性(59.0%对52.4%,P = 0.0012)。此外,与单独的细胞学检查相比,特定的放射学特征(即回声灶和边缘)与细胞学类别相结合提高了特异性(97.5%对91%,P < 0.0001)和阳性预测值(77.5%对50.7%,P < 0.0001),尤其是在不确定结节(TIR3A/III和TIR3B/IV)的情况下,同时保持了出色的敏感性和阴性预测值。与EU - TIRADS相比,ACR - TIRADS系统在甲状腺结节分类中显示出更高的特异性。使用特定的放射学特征提高了细胞学的诊断能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787a/8582424/d347082e5dbf/cancers-13-05439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787a/8582424/d347082e5dbf/cancers-13-05439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787a/8582424/d347082e5dbf/cancers-13-05439-g001.jpg

相似文献

1
Use of Diagnostic Criteria from ACR and EU-TIRADS Systems to Improve the Performance of Cytology in Thyroid Nodule Triage.使用美国风湿病学会(ACR)和欧洲甲状腺影像报告和数据系统(EU-TIRADS)的诊断标准提高甲状腺结节分类中细胞学检查的效能
Cancers (Basel). 2021 Oct 29;13(21):5439. doi: 10.3390/cancers13215439.
2
Analysis of 665 thyroid nodules using both EU-TIRADS and ACR TI-RADS classification systems.使用欧盟甲状腺影像报告和数据系统(EU-TIRADS)及美国放射学会甲状腺影像报告和数据系统(ACR TI-RADS)分类系统对665个甲状腺结节进行分析。
Thyroid Res. 2023 May 8;16(1):12. doi: 10.1186/s13044-023-00155-7.
3
A prospective comparison of ACR-TIRADS and EU-TIRADS in thyroid nodule assessment for FNA-US.ACR-TIRADS和EU-TIRADS在甲状腺结节FNA-US评估中的前瞻性比较。
Clin Endocrinol (Oxf). 2023 Mar;98(3):415-425. doi: 10.1111/cen.14799. Epub 2022 Aug 3.
4
Agreement Between American and European Thyroid Imaging, Reporting, and Data System (TIRADS) in the Diagnosis of 473 Thyroid Nodules From a Single Center in Brazil.美国和欧洲甲状腺影像报告和数据系统(TIRADS)在巴西单中心 473 个甲状腺结节诊断中的一致性。
Endocr Pract. 2021 Nov;27(11):1108-1113. doi: 10.1016/j.eprac.2021.06.008. Epub 2021 Jun 18.
5
Diagnostic Performances of the ACR-TIRADS System in Thyroid Nodules Triage: A Prospective Single Center Study.美国放射学会甲状腺影像报告和数据系统(ACR-TIRADS)在甲状腺结节分类中的诊断效能:一项前瞻性单中心研究
Cancers (Basel). 2021 May 6;13(9):2230. doi: 10.3390/cancers13092230.
6
Comparison of British Thyroid Association, American College of Radiology TIRADS and Artificial Intelligence TIRADS with histological correlation: diagnostic performance for predicting thyroid malignancy and unnecessary fine needle aspiration rate.与组织学相关性的英国甲状腺协会、美国放射学院 TIRADS 和人工智能 TIRADS 的比较:预测甲状腺恶性肿瘤和不必要的细针抽吸率的诊断性能。
Br J Radiol. 2021 Jul 1;94(1123):20201444. doi: 10.1259/bjr.20201444. Epub 2021 Jun 9.
7
Can the American Thyroid Association, K-Tirads, and Acr-Tirads Ultrasound Classification Systems Be Used to Predict Malignancy in Bethesda Category IV Nodules?美国甲状腺协会、K-TIRADS 和 ACR-TIRADS 超声分类系统能否用于预测 Bethesda Ⅳ类结节中的恶性肿瘤?
Endocr Pract. 2020 Sep;26(9):945-952. doi: 10.4158/EP-2020-0024.
8
Comparison of diagnostic accuracy of ACR-TIRADS, American Thyroid Association (ATA), and EU-TIRADS guidelines in detecting thyroid malignancy.ACR-TIRADS、美国甲状腺协会(ATA)和 EU-TIRADS 指南在诊断甲状腺恶性肿瘤中的准确性比较。
Eur J Radiol. 2020 Dec;133:109390. doi: 10.1016/j.ejrad.2020.109390. Epub 2020 Nov 2.
9
Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules.评估 EU-TIRADS 和 ACR-TIRADS 在儿童甲状腺结节患者风险分层中的疗效。
Front Endocrinol (Lausanne). 2022 Nov 22;13:1041464. doi: 10.3389/fendo.2022.1041464. eCollection 2022.
10
Diagnostic Performance of Thyroid Nodule Risk Stratification Systems: Comparison of ACR-TIRADS, EU-TIRADS, K-TIRADS, and ATA Guidelines.甲状腺结节风险分层系统的诊断性能:ACR-TIRADS、EU-TIRADS、K-TIRADS 和 ATA 指南的比较。
Ultrasound Q. 2023 Dec 1;39(4):206-211. doi: 10.1097/RUQ.0000000000000653.

引用本文的文献

1
Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review.贝塞斯达 III 级甲状腺结节恶性风险评估:全面综述。
Endocrine. 2024 Aug;85(2):473-492. doi: 10.1007/s12020-024-03737-z. Epub 2024 Feb 28.
2
Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.在缺乏分子检测的情况下,对可疑结节进行不必要的甲状腺手术率。
Eur Thyroid J. 2023 Oct 11;12(6). doi: 10.1530/ETJ-23-0114. Print 2023 Dec 1.
3
Diagnostic efficiency among Eu-/C-/ACR-TIRADS and S-Detect for thyroid nodules: a systematic review and network meta-analysis.

本文引用的文献

1
Diagnostic Performances of the ACR-TIRADS System in Thyroid Nodules Triage: A Prospective Single Center Study.美国放射学会甲状腺影像报告和数据系统(ACR-TIRADS)在甲状腺结节分类中的诊断效能:一项前瞻性单中心研究
Cancers (Basel). 2021 May 6;13(9):2230. doi: 10.3390/cancers13092230.
2
Comparison of 5 Thyroid Ultrasound Stratification Systems for Differentiation of Benign and Malignant Nodules and to Avoid Biopsy Using Histology as Reference Standard.比较五种甲状腺超声分层系统,以区分良性和恶性结节,并避免使用组织学作为参考标准进行活检。
Endocr Pract. 2021 Nov;27(11):1093-1099. doi: 10.1016/j.eprac.2021.04.411. Epub 2021 Apr 28.
3
超声弹性成像技术在甲状腺结节诊断中的应用价值:一项系统评价和网状 Meta 分析。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1227339. doi: 10.3389/fendo.2023.1227339. eCollection 2023.
4
The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics.儿科甲状腺结节的复杂细胞分子图景
Cancers (Basel). 2023 Mar 29;15(7):2039. doi: 10.3390/cancers15072039.
5
Diagnostic Performance of Various Ultrasound Risk Stratification Systems for Benign and Malignant Thyroid Nodules: A Meta-Analysis.各种超声风险分层系统对甲状腺良恶性结节的诊断性能:一项荟萃分析。
Cancers (Basel). 2023 Jan 9;15(2):424. doi: 10.3390/cancers15020424.
6
Diagnostic Performance of ACR and Kwak TI-RADS for Benign and Malignant Thyroid Nodules: An Update Systematic Review and Meta-Analysis.美国放射学会(ACR)和夸克甲状腺影像报告和数据系统(Kwak TI-RADS)对甲状腺良恶性结节的诊断效能:一项更新的系统评价和荟萃分析
Cancers (Basel). 2022 Dec 2;14(23):5961. doi: 10.3390/cancers14235961.
7
Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules.评估 EU-TIRADS 和 ACR-TIRADS 在儿童甲状腺结节患者风险分层中的疗效。
Front Endocrinol (Lausanne). 2022 Nov 22;13:1041464. doi: 10.3389/fendo.2022.1041464. eCollection 2022.
8
An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma.一份恶性程度不确定的细针穿刺抽吸活检(FNA)报告并不会增加甲状腺意外癌的手术风险。
Cancers (Basel). 2022 Nov 3;14(21):5427. doi: 10.3390/cancers14215427.
9
Multiparametric Sonographic Imaging of Thyroid Lesions: Chances of B-Mode, Elastography and CEUS in Relation to Preoperative Histopathology.甲状腺病变的多参数超声成像:B 模式、弹性成像和对比增强超声与术前组织病理学的关系
Cancers (Basel). 2022 Sep 29;14(19):4745. doi: 10.3390/cancers14194745.
10
The prevalence and associated predictors for Bethesda III-VI for reporting thyroid cytopathology in Royal Commission Hospital, Kingdom of Saudi Arabia.沙特阿拉伯王国皇家委员会医院甲状腺细胞病理学报告中贝塞斯达III-VI级的患病率及相关预测因素。
Ther Adv Endocrinol Metab. 2022 Sep 12;13:20420188221122486. doi: 10.1177/20420188221122486. eCollection 2022.
Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study.
超声与分子检测联合在贝塞斯达四类甲状腺结节恶性风险评估中的应用:单中心前瞻性研究结果。
J Endocrinol Invest. 2021 Dec;44(12):2635-2643. doi: 10.1007/s40618-021-01571-y. Epub 2021 Apr 16.
4
Diagnostic performance of the modified Korean Thyroid Imaging Reporting and Data System for thyroid malignancy according to nodule size: a comparison with five society guidelines.根据结节大小评估改良韩国甲状腺影像报告和数据系统对甲状腺恶性肿瘤的诊断效能:与五项学会指南的比较
Ultrasonography. 2021 Oct;40(4):474-485. doi: 10.14366/usg.20148. Epub 2020 Dec 9.
5
Comparison of Diagnostic Performance of Five Different Ultrasound TI-RADS Classification Guidelines for Thyroid Nodules.五种不同甲状腺影像报告和数据系统(TI-RADS)分类指南对甲状腺结节诊断性能的比较
Front Oncol. 2020 Nov 16;10:598225. doi: 10.3389/fonc.2020.598225. eCollection 2020.
6
Unnecessary thyroid nodule biopsy rates under four ultrasound risk stratification systems: a systematic review and meta-analysis.四种超声风险分层系统下甲状腺结节不必要活检率:系统评价和荟萃分析。
Eur Radiol. 2021 May;31(5):2877-2885. doi: 10.1007/s00330-020-07384-6. Epub 2020 Oct 15.
7
Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard.使用组织学作为参考标准,在真实系列中评估 ACR TI-RADS 和 EU TI-RADS 评分系统在甲状腺结节诊断中的表现。
Eur J Endocrinol. 2020 Nov;183(5):521-528. doi: 10.1530/EJE-20-0682.
8
Outcome and diagnostic reproducibility of the thyroid cytology "indeterminate categories" SIAPEC/SIE 2014 in a consecutive series of 302 cases.302 例连续病例中甲状腺细胞学“不确定类别”SIAPEC/SIE 2014 的结果和诊断可重复性。
J Endocrinol Invest. 2021 Apr;44(4):803-809. doi: 10.1007/s40618-020-01377-4. Epub 2020 Aug 14.
9
Diagnostic performances and unnecessary US-FNA rates of various TIRADS after application of equal size thresholds.不同 TIRADS 应用等大小阈值后的诊断性能和不必要 US-FNA 率。
Sci Rep. 2020 Jun 30;10(1):10632. doi: 10.1038/s41598-020-67543-z.
10
Diagnostic Performance of Four Ultrasound Risk Stratification Systems: A Systematic Review and Meta-Analysis.四种超声风险分层系统的诊断性能:系统评价和荟萃分析。
Thyroid. 2020 Aug;30(8):1159-1168. doi: 10.1089/thy.2019.0812. Epub 2020 May 19.